Overall, these findings highlight that systemic administration of CA IX/XII inhibitors, beyond their effects on the stromal compartment, directly affects the ability of cancer cells to upload exogenous lactic acid, thereby acting as ferroptosis sensitizers. Here, CA9 is linked to cancer.